Lv et al. [35] reported that FABP5 expression was significantly upregulated in ccRCC and patients with a high expression level of FABP5 were correlated with tumor metastasis classifications that were also predicted to have poor survival. The gene discussed is FABP5; the disease is nonpapillary renal cell carcinoma.